Allergan plc has entered into a definitive agreement to acquire Zeltiq for $2.5 billion and Zeltiq Aesthetics, Inc., a medical technology company focused on developing its controlled-cooling technology platform. The transaction is expected to close in 2H17. The acquisition expands Allergan’s medical aesthetics portfolio with the addition of Zeltiq’s flagship CoolSculpting System. The CoolSculpting System is FDA-cleared to affect appearance through lipolysis or reduction of unwante...